Enanta Pharmaceuticals Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Enanta Pharmaceuticals Stock Summary

Enanta Pharmaceuticals competes with Monte Rosa, Design Therapeutics, Werewolf Therapeutics, Ikena Oncology, and Stoke Therapeutics. Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts. Enanta Pharmaceutica operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 155 people.

Enanta Pharmaceuticals Key Financial Ratios

Enanta Pharmaceuticals Key Balance Sheet Accounts

Enanta Pharmaceuticals Key Income Statement Accounts

Enanta Pharmaceuticals Key Cash Accounts

Enanta Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Enanta Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Enanta Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Enanta Pharmaceuticals competition to find correlations between indicators driving Enanta Pharmaceuticals's intrinsic value. More Info.Enanta Pharmaceuticals is rated below average in return on equity category among its peers. It is rated # 3 in return on asset category among its peers . At present, Enanta Pharmaceuticals' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Enanta Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Enanta Pharmaceuticals Systematic Risk

Today, most investors in Enanta Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Enanta Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Enanta Pharmaceuticals growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Enanta Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Enanta Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Enanta Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Enanta Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Enanta Pharmaceuticals's daily price indicators and compare them against related drivers.

When running Enanta Pharmaceuticals' price analysis, check to measure Enanta Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enanta Pharmaceuticals is operating at the current time. Most of Enanta Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Enanta Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enanta Pharmaceuticals' price. Additionally, you may evaluate how the addition of Enanta Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.